BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 25618348)

  • 21. Protein binding site analysis for drug discovery using a computational fragment-based method.
    Ludington JL
    Methods Mol Biol; 2015; 1289():145-54. PubMed ID: 25709039
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identifying the cellular targets of bioactive small molecules with activity-based probes.
    Li X; Hu Y
    Curr Med Chem; 2010; 17(27):3030-44. PubMed ID: 20629628
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Experiences in fragment-based lead discovery.
    Hubbard RE; Murray JB
    Methods Enzymol; 2011; 493():509-31. PubMed ID: 21371604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Maximizing computational tools for successful drug discovery.
    Nantasenamat C; Prachayasittikul V
    Expert Opin Drug Discov; 2015 Apr; 10(4):321-9. PubMed ID: 25693813
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brief Guide: Experimental Strategies for High-Quality Hit Selection from Small-Molecule Screening Campaigns.
    Rothenaigner I; Hadian K
    SLAS Discov; 2021 Aug; 26(7):851-854. PubMed ID: 33882754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Learning from PAINful lessons.
    Erlanson DA
    J Med Chem; 2015 Mar; 58(5):2088-90. PubMed ID: 25710486
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel trends in high-throughput screening.
    Mayr LM; Bojanic D
    Curr Opin Pharmacol; 2009 Oct; 9(5):580-8. PubMed ID: 19775937
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Establish an automated flow injection ESI-MS method for the screening of fragment based libraries: Application to Hsp90.
    Riccardi Sirtori F; Caronni D; Colombo M; Dalvit C; Paolucci M; Regazzoni L; Visco C; Fogliatto G
    Eur J Pharm Sci; 2015 Aug; 76():83-94. PubMed ID: 25952103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Strength and specificity of the CMBA screening platform for bioactive molecules discovery].
    Barette C; Soleilhac E; Charavay C; Cochet C; Fauvarque MO
    Med Sci (Paris); 2015 Apr; 31(4):423-31. PubMed ID: 25958761
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biased and unbiased strategies to identify biologically active small molecules.
    Abet V; Mariani A; Truscott FR; Britton S; Rodriguez R
    Bioorg Med Chem; 2014 Aug; 22(16):4474-89. PubMed ID: 24811300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advancing fragment binders to lead-like compounds using ligand and protein-based NMR spectroscopy.
    Maurer T
    Methods Enzymol; 2011; 493():469-85. PubMed ID: 21371602
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Applications of chemical genetics in biomedical research].
    Jing Q; Zhao J; Zhao B; Zhang S; Miao J
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2009 Apr; 26(2):448-51. PubMed ID: 19499823
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selecting chemicals: the emerging utility of DNA-encoded libraries.
    Clark MA
    Curr Opin Chem Biol; 2010 Jun; 14(3):396-403. PubMed ID: 20346729
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemical proteomics and its impact on the drug discovery process.
    Miao Q; Zhang CC; Kast J
    Expert Rev Proteomics; 2012 Jun; 9(3):281-91. PubMed ID: 22809207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemical genetics to chemical genomics: small molecules offer big insights.
    Spring DR
    Chem Soc Rev; 2005 Jun; 34(6):472-82. PubMed ID: 16137160
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Practical aspects of NMR-based fragment screening.
    Lepre CA
    Methods Enzymol; 2011; 493():219-39. PubMed ID: 21371593
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biodiversity of small molecules--a new perspective in screening set selection.
    Petrone PM; Wassermann AM; Lounkine E; Kutchukian P; Simms B; Jenkins J; Selzer P; Glick M
    Drug Discov Today; 2013 Jul; 18(13-14):674-80. PubMed ID: 23454345
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Perspectives on the discovery of small-molecule modulators for epigenetic processes.
    Lu Q; Quinn AM; Patel MP; Semus SF; Graves AP; Bandyopadhyay D; Pope AJ; Thrall SH
    J Biomol Screen; 2012 Jun; 17(5):555-71. PubMed ID: 22392809
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ligand specificity, privileged substructures and protein druggability from fragment-based screening.
    Barelier S; Krimm I
    Curr Opin Chem Biol; 2011 Aug; 15(4):469-74. PubMed ID: 21411360
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Target deconvolution of bioactive small molecules: the heart of chemical biology and drug discovery.
    Jung HJ; Kwon HJ
    Arch Pharm Res; 2015 Sep; 38(9):1627-41. PubMed ID: 26040984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.